Andere Sprachen Biofrontera Inc.

Aktien

A3EFRZ

US09077D2099

BFRI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 23.05.2024			% 5 Tage	% 1. Jan.
1,06 ^USD	-7,02 %		-2,75 %	-61,73 %

16.05.	Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024
15.05.	Biofrontera Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	15.05.
Biofrontera Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Biofrontera : Certificate of Incorporation/Bylaws - Form 8-K	02.05.
Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15.03.
Biofrontera Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15.03.
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	11.03.
Medicus Pharma Names COO	05.03.
Biofrontera Inc. announced that it has received $8 million in funding	22.02.
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	21.02.
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	21.02.
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera Ag	20.02.
Biofrontera Inc. announced that it expects to receive $8 million in funding	19.02.
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use	05.02.
Certain Warrants of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01.02.
Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01.02.
Certain Stock options of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01.02.
Biofrontera Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	11.01.
Biofrontera Inc. Terminates MidCap Business Credit Loan Agreement	09.01.
Biofrontera Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Biofrontera Inc. Reaffirms Revenue Guidance for the Full Year 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biofrontera Inc.

Aktien

A3EFRZ

US09077D2099

BFRI

Andere Sprachen

Filter